ElGato

ElGato | Joined since 2022-10-13

Investing Experience -
Risk Profile -

Followers

0

Following

0

Blog Posts

0

Threads

36

Blogs

Threads

Portfolio

Follower

Following

Summary
Total comments
36
Past 30 days
1
Past 7 days
0
Today
0

User Comments
Stock

3 weeks ago | Report Abuse

If anyone is interested in buying TauRx shares (trading between $200-300USD) you can PM me. I won't entertain small lots though. ;)

Stock

2023-11-29 08:11 | Report Abuse

@neohts Taurx are moving quietly in the background. Expecting news to come next year. No point posting here if no news.

Stock

2023-09-19 14:00 | Report Abuse

@ClaraChan94, HMTM stands for "Hydromethylthionine Mesylate", it is the latest drug being used for Phase 3 trials for Taurx. It is an upgraded version of "Methylthioninium Chloride (MTC)" that was used for the previous trials.

Stock

2023-09-06 16:11 | Report Abuse

@neohts, Genting Berhad is a major shareholder with 20% of Taurx shares since 2012.

Stock

2023-08-16 16:18 | Report Abuse

@ATK Damn, now lending interest rates climbing, hope you can tahan until year end. Yes I think UK will be first, the rest will fall in line like domino. Just need 1 state/country to approve.

Stock

2023-08-16 15:14 | Report Abuse

@ATK Maybe take some profit EOY, planning to buy a property.

Stock

2023-08-16 13:57 | Report Abuse

@Havefun It's traded privately, current price is around 200-250 USD. Most likely looking for trade sale of the company, unlikely to be IPO.

Stock

2023-07-16 21:27 | Report Abuse

Hiya bro ATK, long time no chat, hope you're well. The data is very solid, hoping a big pharma will come in to take us up once we have regulatory approval or conditional approval at the very least. Don't worry about the trolls, you'll be laughing to the banks when this thing pops.

Stock

2023-07-16 20:35 | Report Abuse

Very good news, Taurx results very well received. Perfect score.

Stock

2023-06-09 14:11 | Report Abuse

@ATK
https://www.dailymail.co.uk/health/article-12166537/Neurologist-paid-20-000-year-biotech-companies-removed-FDA-dementia-panel.html

20K per year to pay off a FDA advisory member. Guessing this guy is just a scapegoat and there are bigger fishes behind him that got off scot-free.

Stock

2023-05-18 21:15 | Report Abuse

@KooSan Preference is given to those that knows how to play ball. Lobbying is a must when it comes to getting approvals in the US. I'm sure the new advisory company that tagged in last year knows it.. which is also a smart move that we are heading to other markets to get approval first.

Stock

2023-05-18 15:50 | Report Abuse

@ATK The whole US government and system is a plutocracy. The government bodies and big pharmas are going to continue to gatekeep to protect their own self interest. Quite sickening really.

Stock

2023-05-08 14:18 | Report Abuse

@ATK If Leqembi and Donanemab gets full approval then chances for C.A for Taurx will be slim to none. It just validates our theory that big pharmas are running the FDA in the shadows. Why would they allow our drug with strong safety profile, high efficacy data and a fraction of their drug price enter the market? Broken healthcare system for a broken country..

Stock

2023-05-04 13:16 | Report Abuse

@ATK Let's not worry too much about what others say. So far all the information you've provided on Taurx are spot on. Personally I don't want to share or divulge too much information since people on this platform also won't appreciate it.

Stock

2023-04-05 00:22 | Report Abuse

@ATK Yup, it's fair lah, every new investor/fund that he brings in will receive a cut of commission shared with broker. Without him, we also won't know about Taurx or have the confidence to invest into it. At the end of the day, its good to collect the profits but more importantly I hope the drug is able to be released to the public as a lot of aging investors whose health have deteriorated and needs this drug to sustain their neuro health. (My folks included)

Stock

2023-04-03 14:06 | Report Abuse

@ATK Yup, should be the same guy. Small world. Mediaring, Biosensors, Herbalscience.. etc.

Stock

2023-03-31 01:22 | Report Abuse

@ATK Very hopeful for CA in China especially with Xinhua News pushing for us.

Stock

2023-03-30 14:50 | Report Abuse

@ATK Pretty sure I know who your Taikor is lol. Also waiting.. think when Ramadan ends will have movement again.

Stock

2023-03-08 15:35 | Report Abuse

@ATK Hello ATK! Too many trolls here and not much good information being shared around so I left for a bit. Hopefully this month will have some good news from the Middle East.

Stock

2023-03-07 15:10 | Report Abuse

@Annetan There is none, it is a private company. Shares are traded privately.

Stock

2023-02-20 14:20 | Report Abuse

@ATK Better chance coming from the UK/Middle East/China than EMA/FDA. I also planning to let go my converted warrants after March/April.

Stock

2023-01-27 17:18 | Report Abuse

@ATK Word on the street is that something big is moving within the Sandy Kingdoms. Expecting announcements next month.

Stock

2023-01-07 16:56 | Report Abuse

@dragon328 And this is just US market alone.

Stock

2022-12-15 17:38 | Report Abuse

Anyone going to Genting for the holidays?

Stock

2022-12-03 12:43 | Report Abuse

Ya I saw that this morning. Seems like Biospace is very positive on Taurx from their posting history.

Stock

2022-12-02 15:13 | Report Abuse

@ATK
Yes but their end points are met, ours not, so have to keep doing trials. I'm keeping an eye on them.

Stock

2022-11-15 14:28 | Report Abuse

Absolutely, Biogen has over 1 hour+ of speaking time with Q&A at the conference while Taurx only has 15 minutes. The odds were already stacked against us in the first place.

Stock

2022-11-15 13:35 | Report Abuse

15 days till CTAD conference in San Fran, another marker for Genting shares.

Stock

2022-10-21 15:48 | Report Abuse

Honestly I would much prefer a trade sale process but safe to also set up IPO as a backup route.

Stock

2022-10-21 15:14 | Report Abuse

@ATK Same, I pumped most of money to exercise the warrants. No money to play around with Genting now.

Stock

2022-10-14 00:34 | Report Abuse

@DestinyL Previously they were awarded the "innovation passport" by the UK drug development regulatory to fast track the approval after their Phase 3 results. (https://www.pressandjournal.co.uk/fp/business/local/4361694/aberdeen-alzheimers-drugs-slows-progress-of-dread-disease/)

From Taurx press release:
"TauRx plans to submit HMTM for regulatory approval in the US and Canada in 2023, with other territories to follow, in line with its overall plans to commercialise HMTM and pursue clinical trials in other related neurodegenerative diseases."

In the other press release, they have engaged a new CMO from EVERSANA to spearhead this process. Taurx has also enlisted 2 specialist law firms to support regulatory submissions from their respective countries. All the info can be found on Taurx's website.

Stock

2022-10-13 17:30 | Report Abuse

@DestinyL If we're purely looking for a US FDA approval.. sure, fair enough. However I believe Taurx is getting approvals from other regions as well.. Canada, UK & Europe.

Stock

2022-10-13 14:53 | Report Abuse

@neohts If Genting don't exercise the Taurx warrants, their shares will get diluted. Honestly just another fund raising round by Taurx to carry them through next year.